HIVE Digital Technologies Zukünftiges Wachstum

Future Kriterienprüfungen 5/6

HIVE Digital Technologies wird ein Gewinn- und Umsatzwachstum von 89.6% bzw. 45.1% pro Jahr prognostiziert, während der Gewinn pro Aktie um 91.9% pro Jahr wachsen soll.

Wichtige Informationen

89.6%

Wachstumsrate der Gewinne

91.9%

EPS-Wachstumsrate

Software Gewinnwachstum29.7%
Wachstumsrate der Einnahmen45.1%
Zukünftige Eigenkapitalrenditen/a
Analystenabdeckung

Good

Zuletzt aktualisiert18 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Why Investors Shouldn't Be Surprised By HIVE Digital Technologies Ltd.'s (CVE:HIVE) 28% Share Price Surge

Oct 19
Why Investors Shouldn't Be Surprised By HIVE Digital Technologies Ltd.'s (CVE:HIVE) 28% Share Price Surge

HIVE Digital Technologies Ltd.'s (CVE:HIVE) 27% Dip In Price Shows Sentiment Is Matching Revenues

Aug 15
HIVE Digital Technologies Ltd.'s (CVE:HIVE) 27% Dip In Price Shows Sentiment Is Matching Revenues

A Piece Of The Puzzle Missing From HIVE Digital Technologies Ltd.'s (CVE:HIVE) 28% Share Price Climb

Jun 13
A Piece Of The Puzzle Missing From HIVE Digital Technologies Ltd.'s (CVE:HIVE) 28% Share Price Climb

Is HIVE Digital Technologies (CVE:HIVE) Using Too Much Debt?

Jun 06
Is HIVE Digital Technologies (CVE:HIVE) Using Too Much Debt?

Slammed 25% HIVE Digital Technologies Ltd. (CVE:HIVE) Screens Well Here But There Might Be A Catch

Mar 23
Slammed 25% HIVE Digital Technologies Ltd. (CVE:HIVE) Screens Well Here But There Might Be A Catch

Market Cool On HIVE Digital Technologies Ltd.'s (CVE:HIVE) Revenues Pushing Shares 28% Lower

Feb 03
Market Cool On HIVE Digital Technologies Ltd.'s (CVE:HIVE) Revenues Pushing Shares 28% Lower

HIVE Digital Technologies Ltd.'s (CVE:HIVE) 25% Jump Shows Its Popularity With Investors

Dec 20
HIVE Digital Technologies Ltd.'s (CVE:HIVE) 25% Jump Shows Its Popularity With Investors

Is HIVE Digital Technologies (CVE:HIVE) Using Too Much Debt?

Oct 11
Is HIVE Digital Technologies (CVE:HIVE) Using Too Much Debt?

Is HIVE Blockchain Technologies (CVE:HIVE) A Risky Investment?

Jun 21
Is HIVE Blockchain Technologies (CVE:HIVE) A Risky Investment?

HIVE Blockchain Technologies (CVE:HIVE) Is Making Moderate Use Of Debt

Mar 10
HIVE Blockchain Technologies (CVE:HIVE) Is Making Moderate Use Of Debt

Under The Bonnet, HIVE Blockchain Technologies' (CVE:HIVE) Returns Look Impressive

Jul 19
Under The Bonnet, HIVE Blockchain Technologies' (CVE:HIVE) Returns Look Impressive

Is Now The Time To Put HIVE Blockchain Technologies (CVE:HIVE) On Your Watchlist?

Jun 12
Is Now The Time To Put HIVE Blockchain Technologies (CVE:HIVE) On Your Watchlist?

HIVE Blockchain Technologies Ltd.'s (CVE:HIVE) 30% Dip In Price Shows Sentiment Is Matching Earnings

Apr 28
HIVE Blockchain Technologies Ltd.'s (CVE:HIVE) 30% Dip In Price Shows Sentiment Is Matching Earnings

HIVE Blockchain Technologies (CVE:HIVE) Could Become A Multi-Bagger

Mar 30
HIVE Blockchain Technologies (CVE:HIVE) Could Become A Multi-Bagger

Do HIVE Blockchain Technologies's (CVE:HIVE) Earnings Warrant Your Attention?

Mar 09
Do HIVE Blockchain Technologies's (CVE:HIVE) Earnings Warrant Your Attention?

Here's Why HIVE Blockchain Technologies (CVE:HIVE) Can Manage Its Debt Responsibly

Feb 16
Here's Why HIVE Blockchain Technologies (CVE:HIVE) Can Manage Its Debt Responsibly

Investors Should Be Encouraged By HIVE Blockchain Technologies' (CVE:HIVE) Returns On Capital

Nov 03
Investors Should Be Encouraged By HIVE Blockchain Technologies' (CVE:HIVE) Returns On Capital

HIVE Blockchain Technologies (CVE:HIVE) Has A Pretty Healthy Balance Sheet

Sep 28
HIVE Blockchain Technologies (CVE:HIVE) Has A Pretty Healthy Balance Sheet

Gewinn- und Umsatzwachstumsprognosen

TSXV:HIVE - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
3/31/202750679N/AN/A1
3/31/202621810-411986
3/31/2025114-35-138-166
9/30/2024123-15-100-13N/A
6/30/2024123-32-84-6N/A
3/31/2024114-51-6614N/A
12/31/202396-41-3631N/A
9/30/202379-128-2431N/A
6/30/202386-137146N/A
3/31/2023106-236245N/A
12/31/2022138-277-4961N/A
9/30/2022192-132-7278N/A
6/30/2022216-60-12676N/A
3/31/202221180-14766N/A
12/31/2021196109-13257N/A
9/30/202114176-9941N/A
6/30/202110046-5929N/A
3/31/20216824-4224N/A
12/31/20203929-221N/A
9/30/2020301515N/A
6/30/202027-5-40N/A
3/31/202029-2-11N/A
12/31/201930-73-1-1N/A
9/30/201934-113-5-5N/A
6/30/201930-130-9-9N/A
3/31/201932-138-2-2N/A
12/31/201835-74-87-19N/A
9/30/201830-37-123-19N/A
6/30/201824-28N/A-16N/A
3/31/201813-26N/A-25N/A
12/31/20173-20N/A-7N/A
9/30/20170-20N/A-1N/A
6/30/2017N/A0N/A-2N/A
3/31/2017N/A-1N/A0N/A
12/31/2016N/A-1N/A-1N/A
9/30/2016N/A-1N/A-1N/A
6/30/2016N/A-1N/A0N/A
3/31/2016N/A-1N/A0N/A
12/31/2015N/A-1N/A0N/A
9/30/2015N/A-1N/A0N/A
6/30/2015N/A-1N/A0N/A
3/31/2015N/A-1N/A0N/A
12/31/2014N/A-1N/A0N/A
9/30/2014N/A-1N/A0N/A
6/30/2014N/A-1N/A0N/A
3/31/2014N/A-1N/A0N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: HIVE wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.3%).

Ertrag vs. Markt: HIVE wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: HIVE wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: HIVEDie Einnahmen des Unternehmens (45.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Canadian (7% pro Jahr).

Hohe Wachstumseinnahmen: HIVEDie Einnahmen des Unternehmens (45.1% pro Jahr) werden voraussichtlich schneller wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von HIVE in 3 Jahren voraussichtlich hoch sein wird


Wachstumsunternehmen entdecken